1 |
Hanly JG, Thompson K, Mccurdy G, et al. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus [J]. J Immunol Methods, 2010, 352(1-2): 147-152.
|
2 |
Maria I, Francesca M, Chelsea B, et al. Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of Anti-dsDNA autoantibodies [J]. J Immunol Res, 2015, 2015: 1-8.
|
3 |
Copple SS, Giles SR, Jaskowski TD, et al. Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization [J]. Am J Clin Pathol, 2012, 137(5): 825-830.
|
4 |
Metry AM, Al Salmi I, Al Balushi F, et al. Systemic lupus erythematous: symptoms and signs at initial presentations [J]. 2019, 18(2): 1-8.
|
5 |
Rekvig OP. Antiinflamm antiallergy agents med chem. The dsDNA, Anti-dsDNA antibody, and lupus nephritis: what we agree on, what must be done, and what the best strategy forward could be [J]. Front Immunol, 2019, 10: 1104.
|
6 |
Matus S, Burgos PV, Bravo-Zehnder M, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis [J]. J Exp Med, 2007, 204(13): 3221-3234.
|
7 |
Zhou X, Chen H, Wei F, et al. 3β-Acetyloxy-oleanolic acid attenuates pristane-induced lupus nephritis by regulating th17 differentiation [J]. J Immunol Res, 2019(3): 2431617.
|
8 |
Au EY, Ip WK, Lau CS. Evaluation of a multiplex flow immunoassay versus conventional assays in detecting autoantibodies in systemic lupus erythematosus [J]. Hong Kong Med J, 2018, 24(3): 261-269.
|
9 |
Mahler M, Fritzler MJ. Anti-dsDNA antibody testing in the clinic: Farr or ELISA? [J]. Nat Clin Pract Rheumatol, 2007, 3(2): 72-73.
|
10 |
Fiegel F, Buhl A, Jaekel HP, et al. Autoantibodies to double-stranded DNA-Intermethod comparison between four commercial immunoassays and a research biosensor-based device [J]. Lupus, 2010, 19(8): 957-964.
|
11 |
江超, 王健, 周瀛,等.BioPlex 2200全自动免疫分析仪检测血清中抗环瓜氨酸肽抗体的临床应用 [J]. 齐齐哈尔医学院学报, 2017, 38(24): 2918-2920.
|
12 |
Martinetti A, Miceli R, Sottotetti E, et al. Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens [J].Cancers (Basel), 2014, 6(3): 1753-1768.
|
13 |
赵瀛, 黄斐, 宋斌斌, 等. BioPlex2200全自动免疫分析仪检测抗环瓜氨酸肽抗体的性能评估 [J]. 检验医学, 2014, 29(2): 153-157.
|